risperidone has been researched along with neuropeptide y in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gruber, SH; Mathé, AA | 1 |
de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A | 1 |
Gruber, SH; Mathé, AA; Nomikos, GG | 1 |
Egerod, KL; Holst, B; Husum, H; Mellerup, E; Secher, A | 1 |
Ak, M; Kursungoz, C; Sutcigil, L; Yanik, T | 1 |
Ak, M; Kursungoz, C; Yanik, T | 1 |
Huang, XF; Li, LY; Lin, S; Shi, YC; Song, ZY; Sun, WW; Yang, HQ | 1 |
Huang, XF; Lin, S; Shi, YC; Wan, XQ; Wang, L; Yang, HQ; Zeng, F; Zhang, ZH | 1 |
1 trial(s) available for risperidone and neuropeptide y
Article | Year |
---|---|
The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Gonadal Steroid Hormones; Humans; Leptin; Middle Aged; Neuropeptide Y; Olanzapine; Pirenzepine; Radioimmunoassay; Risperidone; Schizophrenia; Time Factors; Weight Gain | 2003 |
7 other study(ies) available for risperidone and neuropeptide y
Article | Year |
---|---|
Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Dextroamphetamine; Haloperidol; Male; Microdialysis; Neuropeptide Y; Rats; Rats, Wistar; Risperidone; Sympathomimetics | 2000 |
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Corpus Striatum; Drug Administration Schedule; Drug Interactions; Extracellular Fluid; Haloperidol; Male; Microdialysis; Neuropeptide Y; Neurotensin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Time Factors | 2006 |
Risperidone treatment increases CB1 receptor binding in rat brain.
Topics: Adiponectin; Animals; Antipsychotic Agents; Brain; Cyclohexanols; Dopamine Antagonists; Eating; Ghrelin; Male; Motor Activity; Neuropeptide Y; Pro-Opiomelanocortin; Prolactin; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Ghrelin; Risperidone; RNA, Messenger; Tritium; Weight Gain | 2010 |
Weight gain in risperidone therapy: investigation of peripheral hypothalamic neurohormone levels in psychotic patients.
Topics: alpha-MSH; Antipsychotic Agents; Appetite Regulation; Body Mass Index; Case-Control Studies; Humans; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Risperidone; Treatment Outcome; Weight Gain; Young Adult | 2013 |
Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Antipsychotic Agents; Appetite; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Risperidone; Statistics, Nonparametric | 2015 |
The central mechanism of risperidone-induced hyperprolactinemia.
Topics: Animals; Antipsychotic Agents; Arcuate Nucleus of Hypothalamus; Disease Models, Animal; Female; Hyperprolactinemia; Male; Mice, Inbred C57BL; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Risperidone; Tyrosine 3-Monooxygenase | 2017 |
Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5-HT2c receptor-NPY pathway.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Eating; Female; Mice; Mice, Inbred C57BL; Neuropeptide Y; Receptor, Serotonin, 5-HT2C; Risperidone; Serotonin Antagonists; Signal Transduction; Weight Gain | 2020 |